Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl injection, and oxycodone hydrochloride

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 3, 2010, Pages 547-550

  Gika, Masatoshi ^a   Eguchi, Keisuke ^b   Inoue, Yoshiaki ^b   Izawa, Naoko ^b   Takeuchi, Ken ^b   Nakayama, Mitsuo ^b  

^a Palliative Care Team ^*  (Japan)

^b Department of Gastroenterology   (Japan)

Author keywords

Cancer pain; Dyspnea; Fentanyl; Oxycodone; Recurrence of lung cancer; Titration

Indexed keywords

BETAMETHASONE; DUROTEP; FENTANYL; OXYCODONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CARCINOMATOUS LYMPHANGITIS; CASE REPORT; DISEASE COURSE; DRUG DOSE TITRATION; DYSPNEA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SURGERY; LYMPHANGITIS; LYMPHATIC SYSTEM TUMOR; OPTIMAL DRUG DOSE; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 79960799922     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Bruera E, Macmillan K, Pither J and MacDonald RN: Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 5(6): 341-344, 1990.
2. Bruera E, MacEachem T, Ripamonti C, et al: Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119(9): 906-907, 1993. (Pubitemid 23316875)
3. Mazzocato C, Buclin T and Rapin CH: The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol 10(12): 1511-1514, 1999. (Pubitemid 30017064)